{
  "id": 14705288,
  "title": "Gilead is teaming up with Vir on solid tumor cancer drugs in a deal worth up to $1.9 billion",
  "url": "https://urgent.news/2026/10/15/gilead-is-teaming-up-with-vir-on-solid-tumor-cancer-drugs-in-a-deal",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-15T13:00:28.000Z",
  "source": {
    "name": "Quartz",
    "slug": "quartz",
    "url": "https://qz.com/gilead-vir-biotechnology-solid-tumor-cancer-deal-101526"
  },
  "original_language": "en",
  "account": null,
  "summary": "Vir Biotechnology will receive $90 million upfront and could earn up to $1.74 billion in later milestone payments",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}